Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.
Identifieur interne : 000B70 ( Istex/Corpus ); précédent : 000B69; suivant : 000B71Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.
Auteurs : E S Lo ; Y M Lo ; C H Tse ; K A FlemingSource :
- Journal of Clinical Pathology [ 0021-9746 ] ; 1992-08.
English descriptors
- Teeft :
- Acute hepatitis, Allele, Allele specificity, Amplification, Amplification phase, Annealing temperature, Assay, Base pair, Chronic hepatitis, Clin pathol, Clinical samples, Clinical specimen, Diagnostic phase, Fulminant, Fulminant hepatitis, Hepatitis, Hong kong, Internal control, Liver biopsy specimens, Liver tissues, Mutagenesis primers, Mutant, Mutant sequence, Mutant sequences, Mutant template, Mutant virus, Mutant viruses, Mutation, Nuffield department, Paraffin, Polymerase, Polymerase chain reaction, Positive control, Precore region, Preliminary investigation, Primer, Queen elizabeth hospital, Relative locations, Sequence specificity, Severe hepatitis, Viral variants, Virus type, Wild type, Wild type template, Wild type virus.
Abstract
AIM: Development of a specific polymerase chain reaction (PCR) assay for detection of the pre-core, stop codon, mutant of hepatitis B virus (HBV). METHODS: PCR primers, specific at the 3'-end for nucleotide 1896 of either the pre-core, stop codon, mutant or wild type HBV, were synthesised using published sequence data. Positive control templates for both types of virus were synthesised by the PCR, incorporating sequences specific for each virus type at the appropriate position. These templates were used to optimise the specificity of the procedure. Formalin fixed, paraffin wax embedded human tissue from acute or fulminant HBV hepatitis from Hong Kong or Oxford was then investigated for presence of mutant or wild type virus. The HBV DNA was amplified from this tissue using a two step procedure, with an initial amplification phase followed by a second diagnostic phase on optimally diluted target DNA. RESULTS: Specific detection of mutant or wild type HBV was achieved. An important factor in determining specificity was the temperature of annealing, 70 degrees C proving to be highly specific. To overcome the inherent variation of target copy number in clinical samples and to provide an intrinsic positive control, it was important to generate and standardise the amount of target HBV used for the specific PCR. Two cases of fulminant hepatitis and four cases of acute hepatitis from Hong Kong, and one case of fulminant hepatitis from Oxford, contained only wild type HBV, with no evidence of a mutant virus. CONCLUSION: This method can be applied to FFPE tissues. It is rapid, non-radioactive, and specific for the stop codon mutation at nucleotide 1896 of HBV. Preliminary investigation of a small number of cases of fulminant hepatitis from Oxford and Hong Kong showed only wild type virus. The result differs from results published from Japan and Israel.
Url:
DOI: 10.1136/jcp.45.8.689
Links to Exploration step
ISTEX:4B749ABE71DC3198C91B746E2E9DB5568F8D0B46Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.</title><author><name sortKey="Lo, E S" sort="Lo, E S" uniqKey="Lo E" first="E S" last="Lo">E S Lo</name><affiliation><mods:affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</mods:affiliation></affiliation></author><author><name sortKey="Lo, Y M" sort="Lo, Y M" uniqKey="Lo Y" first="Y M" last="Lo">Y M Lo</name><affiliation><mods:affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</mods:affiliation></affiliation></author><author><name sortKey="Tse, C H" sort="Tse, C H" uniqKey="Tse C" first="C H" last="Tse">C H Tse</name><affiliation><mods:affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</mods:affiliation></affiliation></author><author><name sortKey="Fleming, K A" sort="Fleming, K A" uniqKey="Fleming K" first="K A" last="Fleming">K A Fleming</name><affiliation><mods:affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4B749ABE71DC3198C91B746E2E9DB5568F8D0B46</idno><date when="1992" year="1992">1992</date><idno type="doi">10.1136/jcp.45.8.689</idno><idno type="url">https://api.istex.fr/ark:/67375/NVC-GS61FN93-L/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000B70</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000B70</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.</title><author><name sortKey="Lo, E S" sort="Lo, E S" uniqKey="Lo E" first="E S" last="Lo">E S Lo</name><affiliation><mods:affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</mods:affiliation></affiliation></author><author><name sortKey="Lo, Y M" sort="Lo, Y M" uniqKey="Lo Y" first="Y M" last="Lo">Y M Lo</name><affiliation><mods:affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</mods:affiliation></affiliation></author><author><name sortKey="Tse, C H" sort="Tse, C H" uniqKey="Tse C" first="C H" last="Tse">C H Tse</name><affiliation><mods:affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</mods:affiliation></affiliation></author><author><name sortKey="Fleming, K A" sort="Fleming, K A" uniqKey="Fleming K" first="K A" last="Fleming">K A Fleming</name><affiliation><mods:affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Clinical Pathology</title><title level="j" type="abbrev">J Clin Pathol</title><idno type="ISSN">0021-9746</idno><idno type="eISSN">1472-4146</idno><imprint><publisher>BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><date type="published" when="1992-08">1992-08</date><biblScope unit="volume">45</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="689">689</biblScope></imprint><idno type="ISSN">0021-9746</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0021-9746</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acute hepatitis</term><term>Allele</term><term>Allele specificity</term><term>Amplification</term><term>Amplification phase</term><term>Annealing temperature</term><term>Assay</term><term>Base pair</term><term>Chronic hepatitis</term><term>Clin pathol</term><term>Clinical samples</term><term>Clinical specimen</term><term>Diagnostic phase</term><term>Fulminant</term><term>Fulminant hepatitis</term><term>Hepatitis</term><term>Hong kong</term><term>Internal control</term><term>Liver biopsy specimens</term><term>Liver tissues</term><term>Mutagenesis primers</term><term>Mutant</term><term>Mutant sequence</term><term>Mutant sequences</term><term>Mutant template</term><term>Mutant virus</term><term>Mutant viruses</term><term>Mutation</term><term>Nuffield department</term><term>Paraffin</term><term>Polymerase</term><term>Polymerase chain reaction</term><term>Positive control</term><term>Precore region</term><term>Preliminary investigation</term><term>Primer</term><term>Queen elizabeth hospital</term><term>Relative locations</term><term>Sequence specificity</term><term>Severe hepatitis</term><term>Viral variants</term><term>Virus type</term><term>Wild type</term><term>Wild type template</term><term>Wild type virus</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">AIM: Development of a specific polymerase chain reaction (PCR) assay for detection of the pre-core, stop codon, mutant of hepatitis B virus (HBV). METHODS: PCR primers, specific at the 3'-end for nucleotide 1896 of either the pre-core, stop codon, mutant or wild type HBV, were synthesised using published sequence data. Positive control templates for both types of virus were synthesised by the PCR, incorporating sequences specific for each virus type at the appropriate position. These templates were used to optimise the specificity of the procedure. Formalin fixed, paraffin wax embedded human tissue from acute or fulminant HBV hepatitis from Hong Kong or Oxford was then investigated for presence of mutant or wild type virus. The HBV DNA was amplified from this tissue using a two step procedure, with an initial amplification phase followed by a second diagnostic phase on optimally diluted target DNA. RESULTS: Specific detection of mutant or wild type HBV was achieved. An important factor in determining specificity was the temperature of annealing, 70 degrees C proving to be highly specific. To overcome the inherent variation of target copy number in clinical samples and to provide an intrinsic positive control, it was important to generate and standardise the amount of target HBV used for the specific PCR. Two cases of fulminant hepatitis and four cases of acute hepatitis from Hong Kong, and one case of fulminant hepatitis from Oxford, contained only wild type HBV, with no evidence of a mutant virus. CONCLUSION: This method can be applied to FFPE tissues. It is rapid, non-radioactive, and specific for the stop codon mutation at nucleotide 1896 of HBV. Preliminary investigation of a small number of cases of fulminant hepatitis from Oxford and Hong Kong showed only wild type virus. The result differs from results published from Japan and Israel.</div></front></TEI><istex><corpusName>bmj</corpusName><keywords><teeft><json:string>mutant</json:string><json:string>primer</json:string><json:string>allele</json:string><json:string>fulminant</json:string><json:string>fulminant hepatitis</json:string><json:string>wild type</json:string><json:string>paraffin</json:string><json:string>polymerase</json:string><json:string>mutation</json:string><json:string>hong kong</json:string><json:string>hepatitis</json:string><json:string>polymerase chain reaction</json:string><json:string>diagnostic phase</json:string><json:string>clinical samples</json:string><json:string>mutant virus</json:string><json:string>amplification phase</json:string><json:string>base pair</json:string><json:string>amplification</json:string><json:string>assay</json:string><json:string>chronic hepatitis</json:string><json:string>acute hepatitis</json:string><json:string>mutagenesis primers</json:string><json:string>mutant sequences</json:string><json:string>wild type virus</json:string><json:string>allele specificity</json:string><json:string>liver biopsy specimens</json:string><json:string>liver tissues</json:string><json:string>relative locations</json:string><json:string>nuffield department</json:string><json:string>preliminary investigation</json:string><json:string>queen elizabeth hospital</json:string><json:string>mutant sequence</json:string><json:string>sequence specificity</json:string><json:string>annealing temperature</json:string><json:string>mutant template</json:string><json:string>wild type template</json:string><json:string>clinical specimen</json:string><json:string>clin pathol</json:string><json:string>virus type</json:string><json:string>internal control</json:string><json:string>positive control</json:string><json:string>viral variants</json:string><json:string>severe hepatitis</json:string><json:string>precore region</json:string><json:string>mutant viruses</json:string></teeft></keywords><author><json:item><name>E S Lo</name><affiliations><json:string>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</json:string></affiliations></json:item><json:item><name>Y M Lo</name><affiliations><json:string>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</json:string></affiliations></json:item><json:item><name>C H Tse</name><affiliations><json:string>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</json:string></affiliations></json:item><json:item><name>K A Fleming</name><affiliations><json:string>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</json:string></affiliations></json:item></author><arkIstex>ark:/67375/NVC-GS61FN93-L</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>research-article</json:string></originalGenre><abstract>AIM: Development of a specific polymerase chain reaction (PCR) assay for detection of the pre-core, stop codon, mutant of hepatitis B virus (HBV). METHODS: PCR primers, specific at the 3'-end for nucleotide 1896 of either the pre-core, stop codon, mutant or wild type HBV, were synthesised using published sequence data. Positive control templates for both types of virus were synthesised by the PCR, incorporating sequences specific for each virus type at the appropriate position. These templates were used to optimise the specificity of the procedure. Formalin fixed, paraffin wax embedded human tissue from acute or fulminant HBV hepatitis from Hong Kong or Oxford was then investigated for presence of mutant or wild type virus. The HBV DNA was amplified from this tissue using a two step procedure, with an initial amplification phase followed by a second diagnostic phase on optimally diluted target DNA. RESULTS: Specific detection of mutant or wild type HBV was achieved. An important factor in determining specificity was the temperature of annealing, 70 degrees C proving to be highly specific. To overcome the inherent variation of target copy number in clinical samples and to provide an intrinsic positive control, it was important to generate and standardise the amount of target HBV used for the specific PCR. Two cases of fulminant hepatitis and four cases of acute hepatitis from Hong Kong, and one case of fulminant hepatitis from Oxford, contained only wild type HBV, with no evidence of a mutant virus. CONCLUSION: This method can be applied to FFPE tissues. It is rapid, non-radioactive, and specific for the stop codon mutation at nucleotide 1896 of HBV. Preliminary investigation of a small number of cases of fulminant hepatitis from Oxford and Hong Kong showed only wild type virus. The result differs from results published from Japan and Israel.</abstract><qualityIndicators><score>7.507</score><pdfWordCount>2507</pdfWordCount><pdfCharCount>15997</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>4</pdfPageCount><pdfPageSize>595.27 x 841.89 pts (A4)</pdfPageSize><refBibsNative>false</refBibsNative><abstractWordCount>299</abstractWordCount><abstractCharCount>1873</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.</title><pmid><json:string>1401178</json:string></pmid><genre><json:string>research-article</json:string></genre><host><title>Journal of Clinical Pathology</title><language><json:string>unknown</json:string></language><issn><json:string>0021-9746</json:string></issn><eissn><json:string>1472-4146</json:string></eissn><volume>45</volume><issue>8</issue><pages><first>689</first></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>1992-08-01</json:string></date><geogName></geogName><orgName><json:string>Nuffield Department of Pathology and Bacteriology</json:string><json:string>Japan and Israel</json:string><json:string>Fleming Institute of Pathology, Queen Elizabeth Hospital, Wylie Road, Kowloon, Hong Kong</json:string><json:string>John Radcliffe Hospital, Oxford OX</json:string><json:string>Institute of Pathology, Queen Elizabeth Hospital, Hong Kong</json:string><json:string>Foundation Fellowship</json:string><json:string>Foulkes</json:string><json:string>Wellcome Trust</json:string></orgName><orgName_funder><json:string>Foulkes</json:string><json:string>Wellcome Trust</json:string></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Hong Kong</json:string><json:string>K. Expression</json:string><json:string>Kong</json:string><json:string>Elmer Cetus</json:string></persName><placeName><json:string>Yokosuka</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Kaneko et al.</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/NVC-GS61FN93-L</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - pathology</json:string></wos><scienceMetrix></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - General Medicine</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Pathology and Forensic Medicine</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>1992</publicationDate><copyrightDate>1992</copyrightDate><doi><json:string>10.1136/jcp.45.8.689</json:string></doi><id>4B749ABE71DC3198C91B746E2E9DB5568F8D0B46</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-GS61FN93-L/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-GS61FN93-L/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/NVC-GS61FN93-L/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.</title><respStmt><resp>Références bibliographiques récupérées via GROBID</resp><name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://publisher-list.data.istex.fr">BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><availability><licence><p>© British Medical Journal Publishing Group</p></licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</p></availability><date>1992-08-01</date></publicationStmt><notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.</title><author xml:id="author-0000"><persName><forename type="first">E S</forename><surname>Lo</surname></persName><affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</affiliation></author><author xml:id="author-0001"><persName><forename type="first">Y M</forename><surname>Lo</surname></persName><affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</affiliation></author><author xml:id="author-0002"><persName><forename type="first">C H</forename><surname>Tse</surname></persName><affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</affiliation></author><author xml:id="author-0003"><persName><forename type="first">K A</forename><surname>Fleming</surname></persName><affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</affiliation></author><idno type="istex">4B749ABE71DC3198C91B746E2E9DB5568F8D0B46</idno><idno type="ark">ark:/67375/NVC-GS61FN93-L</idno><idno type="DOI">10.1136/jcp.45.8.689</idno><idno type="href">jclinpath-45-689.pdf</idno><idno type="PMID">1401178</idno><idno type="local">jclinpath;45/8/689</idno></analytic><monogr><title level="j">Journal of Clinical Pathology</title><title level="j" type="abbrev">J Clin Pathol</title><idno type="pISSN">0021-9746</idno><idno type="eISSN">1472-4146</idno><idno type="PublisherID-hwp">jclinpath</idno><idno type="PublisherID-nlm-ta">J Clin Pathol</idno><imprint><publisher>BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><date type="published" when="1992-08"></date><biblScope unit="volume">45</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="689">689</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1992-08-01</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>AIM: Development of a specific polymerase chain reaction (PCR) assay for detection of the pre-core, stop codon, mutant of hepatitis B virus (HBV). METHODS: PCR primers, specific at the 3'-end for nucleotide 1896 of either the pre-core, stop codon, mutant or wild type HBV, were synthesised using published sequence data. Positive control templates for both types of virus were synthesised by the PCR, incorporating sequences specific for each virus type at the appropriate position. These templates were used to optimise the specificity of the procedure. Formalin fixed, paraffin wax embedded human tissue from acute or fulminant HBV hepatitis from Hong Kong or Oxford was then investigated for presence of mutant or wild type virus. The HBV DNA was amplified from this tissue using a two step procedure, with an initial amplification phase followed by a second diagnostic phase on optimally diluted target DNA. RESULTS: Specific detection of mutant or wild type HBV was achieved. An important factor in determining specificity was the temperature of annealing, 70 degrees C proving to be highly specific. To overcome the inherent variation of target copy number in clinical samples and to provide an intrinsic positive control, it was important to generate and standardise the amount of target HBV used for the specific PCR. Two cases of fulminant hepatitis and four cases of acute hepatitis from Hong Kong, and one case of fulminant hepatitis from Oxford, contained only wild type HBV, with no evidence of a mutant virus. CONCLUSION: This method can be applied to FFPE tissues. It is rapid, non-radioactive, and specific for the stop codon mutation at nucleotide 1896 of HBV. Preliminary investigation of a small number of cases of fulminant hepatitis from Oxford and Hong Kong showed only wild type virus. The result differs from results published from Japan and Israel.</p></abstract></profileDesc><revisionDesc><change when="1992-08-01">Created</change><change when="1992-08">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2017-10-17">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-GS61FN93-L/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="hwp">jclinpath</journal-id><journal-id journal-id-type="nlm-ta">J Clin Pathol</journal-id><journal-title>Journal of Clinical Pathology</journal-title><abbrev-journal-title abbrev-type="publisher">J Clin Pathol</abbrev-journal-title><issn pub-type="ppub">0021-9746</issn><issn pub-type="epub">1472-4146</issn><publisher><publisher-name>BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">1401178</article-id><article-id pub-id-type="other">jclinpath;45/8/689</article-id><article-id pub-id-type="doi">10.1136/jcp.45.8.689</article-id><article-id pub-id-type="other">689</article-id><article-id pub-id-type="other">jcp.45.8.689</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lo</surname><given-names>E S</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lo</surname><given-names>Y M</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tse</surname><given-names>C H</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fleming</surname><given-names>K A</given-names></name></contrib></contrib-group><aff>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</aff><pub-date pub-type="ppub"><month>8</month><year>1992</year></pub-date><pub-date pub-type="epub"><day>1</day><month>8</month><year>1992</year></pub-date><volume>45</volume><volume-id pub-id-type="other">45</volume-id><volume-id pub-id-type="other">45</volume-id><issue>8</issue><issue-id pub-id-type="other">jclinpath;45/8</issue-id><issue-id pub-id-type="other">8</issue-id><issue-id pub-id-type="other">45/8</issue-id><fpage>689</fpage><self-uri content-type="pdf" xlink:role="full-text" xlink:href="jclinpath-45-689.pdf"></self-uri><abstract><p>AIM: Development of a specific polymerase chain reaction (PCR) assay for detection of the pre-core, stop codon, mutant of hepatitis B virus (HBV). METHODS: PCR primers, specific at the 3'-end for nucleotide 1896 of either the pre-core, stop codon, mutant or wild type HBV, were synthesised using published sequence data. Positive control templates for both types of virus were synthesised by the PCR, incorporating sequences specific for each virus type at the appropriate position. These templates were used to optimise the specificity of the procedure. Formalin fixed, paraffin wax embedded human tissue from acute or fulminant HBV hepatitis from Hong Kong or Oxford was then investigated for presence of mutant or wild type virus. The HBV DNA was amplified from this tissue using a two step procedure, with an initial amplification phase followed by a second diagnostic phase on optimally diluted target DNA. RESULTS: Specific detection of mutant or wild type HBV was achieved. An important factor in determining specificity was the temperature of annealing, 70 degrees C proving to be highly specific. To overcome the inherent variation of target copy number in clinical samples and to provide an intrinsic positive control, it was important to generate and standardise the amount of target HBV used for the specific PCR. Two cases of fulminant hepatitis and four cases of acute hepatitis from Hong Kong, and one case of fulminant hepatitis from Oxford, contained only wild type HBV, with no evidence of a mutant virus. CONCLUSION: This method can be applied to FFPE tissues. It is rapid, non-radioactive, and specific for the stop codon mutation at nucleotide 1896 of HBV. Preliminary investigation of a small number of cases of fulminant hepatitis from Oxford and Hong Kong showed only wild type virus. The result differs from results published from Japan and Israel.</p></abstract></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.</title></titleInfo><name type="personal"><namePart type="given">E S</namePart><namePart type="family">Lo</namePart><affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y M</namePart><namePart type="family">Lo</namePart><affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C H</namePart><namePart type="family">Tse</namePart><affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K A</namePart><namePart type="family">Fleming</namePart><affiliation>University of Oxford, Nuffield Department of Pathology and Bacteriology, John Radcliffe Hospital.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="research-article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><dateIssued encoding="w3cdtf">1992-08</dateIssued><dateCreated encoding="w3cdtf">1992-08-01</dateCreated><copyrightDate encoding="w3cdtf">1992</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><abstract lang="en">AIM: Development of a specific polymerase chain reaction (PCR) assay for detection of the pre-core, stop codon, mutant of hepatitis B virus (HBV). METHODS: PCR primers, specific at the 3'-end for nucleotide 1896 of either the pre-core, stop codon, mutant or wild type HBV, were synthesised using published sequence data. Positive control templates for both types of virus were synthesised by the PCR, incorporating sequences specific for each virus type at the appropriate position. These templates were used to optimise the specificity of the procedure. Formalin fixed, paraffin wax embedded human tissue from acute or fulminant HBV hepatitis from Hong Kong or Oxford was then investigated for presence of mutant or wild type virus. The HBV DNA was amplified from this tissue using a two step procedure, with an initial amplification phase followed by a second diagnostic phase on optimally diluted target DNA. RESULTS: Specific detection of mutant or wild type HBV was achieved. An important factor in determining specificity was the temperature of annealing, 70 degrees C proving to be highly specific. To overcome the inherent variation of target copy number in clinical samples and to provide an intrinsic positive control, it was important to generate and standardise the amount of target HBV used for the specific PCR. Two cases of fulminant hepatitis and four cases of acute hepatitis from Hong Kong, and one case of fulminant hepatitis from Oxford, contained only wild type HBV, with no evidence of a mutant virus. CONCLUSION: This method can be applied to FFPE tissues. It is rapid, non-radioactive, and specific for the stop codon mutation at nucleotide 1896 of HBV. Preliminary investigation of a small number of cases of fulminant hepatitis from Oxford and Hong Kong showed only wild type virus. The result differs from results published from Japan and Israel.</abstract><relatedItem type="host"><titleInfo><title>Journal of Clinical Pathology</title></titleInfo><titleInfo type="abbreviated"><title>J Clin Pathol</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><identifier type="ISSN">0021-9746</identifier><identifier type="eISSN">1472-4146</identifier><identifier type="PublisherID-hwp">jclinpath</identifier><identifier type="PublisherID-nlm-ta">J Clin Pathol</identifier><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><detail type="issue"><caption>no.</caption><number>8</number></detail><extent unit="pages"><start>689</start></extent></part></relatedItem><identifier type="istex">4B749ABE71DC3198C91B746E2E9DB5568F8D0B46</identifier><identifier type="ark">ark:/67375/NVC-GS61FN93-L</identifier><identifier type="DOI">10.1136/jcp.45.8.689</identifier><identifier type="href">jclinpath-45-689.pdf</identifier><identifier type="PMID">1401178</identifier><identifier type="local">jclinpath;45/8/689</identifier><accessCondition type="use and reproduction" contentType="copyright">© British Medical Journal Publishing Group</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</recordContentSource><recordOrigin>© British Medical Journal Publishing Group</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-GS61FN93-L/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B70 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B70 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:4B749ABE71DC3198C91B746E2E9DB5568F8D0B46
|texte= Detection of hepatitis B pre-core mutant by allele specific polymerase chain reaction.
}}
| This area was generated with Dilib version V0.6.33. |  |